MINOO MCFARLAND: Open Payments
NPI 1861515728 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,476 in 94 payments from 21 companies in 2025. Trend: 2023 $2,354 · 2024 $1,962 · 2025 $2,476
Food & beverage: $2,368Education: $95Consulting: $14
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $404 |
| GlaxoSmithKline, LLC. | 18 | $369 |
| AstraZeneca Pharmaceuticals LP | 15 | $362 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $206 |
| Optinose US, Inc. | 9 | $182 |
| Regeneron Healthcare Solutions, Inc. | 3 | $166 |
| CSL Behring | 6 | $154 |
| PFIZER INC. | 2 | $146 |
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| Amgen Inc. | 3 | $60 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, NEFFY, Xhance, Hizentra, TRELEGY ELLIPTA, CIBINQO.
Industry payments across VA — which companies pay providers there.
